Source of severe morning sickness found in new study, providing potential relief during pregnancy
New Study Finds Hormone Responsible for Severe Morning Sickness
A groundbreaking study conducted by the University of Cambridge has revealed that a hormone called GDF15 is responsible for causing severe morning sickness, also known as hyperemesis gravidarum, in pregnant women. This finding could potentially lead to improved treatment options and even preventative measures for women suffering from this debilitating condition.
The study, which involved 120 pregnant women, found that those who experienced nausea and vomiting had significantly higher levels of GDF15 compared to those with little or no morning sickness. GDF15 is primarily produced by the fetus during early pregnancy, and some women are more sensitive to the hormone, putting them at higher risk for developing severe morning sickness.
The hope is that this discovery will pave the way for more effective treatment options for hyperemesis gravidarum. Currently, the condition affects only about 0.3% to 2% of pregnant women and can be extremely debilitating, making it difficult for them to eat, drink, and participate in daily activities. Some common signs of hyperemesis gravidarum include frequent vomiting, severe dehydration, and significant weight loss.
Interestingly, the study also found that women with higher levels of GDF15 before getting pregnant were less likely to develop severe sickness. This suggests that administering the hormone to high-risk women before pregnancy may help prevent severe symptoms from occurring.
To further explore the potential use of GDF15 in preventing and treating hyperemesis gravidarum, clinical trials are currently being planned. However, the study authors caution that GDF15 levels alone cannot be used as a diagnostic test for hyperemesis gravidarum, as other factors may also influence the risk of developing the condition.
Overall, this research represents a significant step forward in understanding the causes of severe morning sickness and offers hope for women who suffer from hyperemesis gravidarum. With further investigation and development, GDF15 could potentially provide relief and support to countless pregnant women around the world.
“Pop culture advocate. Troublemaker. Friendly student. Proud problem solver.”
